Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Studying the three peptides as a combined preparation
As GLOW has no trial-established dose, the derived range is 1.4-4.2 mg per injection: Low Dose: 1.4 mg (1 mg GHK-Cu + 200 mcg BPC-157 + 200 mcg TB-4) Standard Dose: 2.8 mg (2 mg GHK-Cu + 400 mcg BPC-157 + 400 mcg TB-4) Elevated Dose: 4.2 mg (3 mg GHK-Cu + 600 mcg BPC-157 + 600 mcg TB-4) What is the GLOW dose per day
Potential Research Focus Areas (preclinical signals): Soft-Tissue Remodeling: fibroblast activity, ECM deposition, epithelial closure Vascular Support: pro-angiogenic signaling and perfusion metrics Inflammation & Resolution: cytokine balance, pro-resolution mediators Cytoskeletal Dynamics: G-actin interactions and cell motility pathways For Laboratory Research Use Only
What Human Studies on the Effects of BPC-157 Actually Show Before going further, it's worth being clear about how lacking the human evidence really is
Scientists analyzed 12 randomized, placebo-controlled trials involving 738 adults with hypertension
